MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-02-0058462
Therallen Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹52.29 Cr
▲ 34% YoY
Net profit · FY 2025
₹1.66 Cr
Net margin 3.2%
EBITDA · FY 2025
₹2.38 Cr
EBITDA margin 4.5%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹9.65 Cr
Issued & subscribed
Open charges
₹2.5 Cr
Secured borrowings
Company age
9 yrs
Est. 2017
Employees · EPFO
106
Provident fund records
About Therallen Pharma Private Limited
Data last updated:
Therallen Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 August 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24110TG2017PTC119091. Its GSTIN is 36AAGCT4007R1ZW (Telangana).
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹9.65 Cr. It is led by directors Srinivasa Rao Yalamanchili (Whole-Time Director) and Smitha Yalamanchili.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹52.29 Cr, a growth of 34% compared to the previous year. For the same year it recorded a net profit of ₹1.66 Cr (net margin 3.2%) and EBITDA of ₹2.38 Cr (EBITDA margin 4.5%). Revenue has grown at a compounded annual rate (CAGR) of 41% over three years and 44% over five years.
The company has about 106 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Therallen Pharma. As per MCA filings, the company has open charges of ₹2.5 Cr on record.
Therallen Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0058462). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website therallen.com.
Company details
CIN U24110TG2017PTC119091
Registration Number 119091
Incorporation Date 24 August 2017
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-02-0058462
Recognitions & Rankings of Therallen Pharma
Contact details
Therallen Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is therallen.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressPlot No. 67 1st Floor Jubilee Enclave, Chitiprolu Arcade Hitech City, Hyderabad, Telangana, India – 500081
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Therallen Pharma Private Limited, buy the company report.
Comprehensive company report
Therallen Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Therallen Pharma operates one associated brand: Therallen Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| A research-driven company focused on innovative drug delivery systems and new product development. | therallen.com |
Business activity
The main business activity of Therallen Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Therallen Pharma Private Limited, buy the company report.
Financials of Therallen Pharma Private Limited
FY 2025 filings availableTherallen Pharma Private Limited reported revenue of ₹52.29 Cr (up 34% YoY) for FY 2025.
Revenue · FY 2025
₹52.29 Cr ▲ 34%
Net profit · FY 2025
₹1.66 Cr margin 3.2%
EBITDA · FY 2025
₹2.38 Cr margin 4.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 34%
3 years · compounded
▲ 41%
5 years · compounded
▲ 44%
EBITDA CAGR growth
1 year
▲ 890%
3 years · compounded
▲ 34%
5 years · compounded
▲ 22%
Revenue has grown at a compounded annual rate (CAGR) of 44% over five years, including 34% growth in the latest year. EBITDA rose 890% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.38 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.66 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.5% | ||||
| Net Profit Margin | 3.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Therallen Pharma Private Limited, buy the company report.
Board of directors of Therallen Pharma Private Limited
Therallen Pharma has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinivasa Rao Yalamanchili | Whole-Time Director | 03 May 2021 | 5 Years 6 Months | Current |
| Smitha Yalamanchili | Director | 21 Dec 2023 | 2 Years 10 Months | Current |
Peer comparison
Therallen Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pharma Synth Formulations Limited | ₹53.06 Cr (FY 2024) | 1.0% | Delhi, India | |||
| Prerana Agrochem Private Limited | ₹52.43 Cr (FY 2025) | 253.0% | Bharuch, Gujarat, India | |||
| Unilink Pharma Private Limited | ₹52.34 Cr (FY 2024) | -18.0% | Chennai, Tamil Nadu, India | |||
| Therallen Pharma Private Limitedthis company | ₹52.29 Cr (FY 2025) | ₹1.66 Cr | 3.2% | 34.0% | 106 | Hyderabad, Telangana, India |
| Intracin Pharmaceuticals Private Limited | ₹52.07 Cr (FY 2024) | 39.0% | Nadiad, Gujarat, India | |||
| Ranq Pharmaceuticals and Excipients Private Limited | ₹51.83 Cr (FY 2025) | 5.0% | Thane, Maharashtra, India | |||
| Smayan Healthcare Private Limited | ₹51.72 Cr (FY 2024) | 19.0% | Chandigarh, India |
To see the full peer comparison of Therallen Pharma Private Limited, buy the company report.
Auditor
Therallen Pharma Private Limited is audited by ANANT RAO & MALLIK for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANANT RAO & MALLIK | FY 2022 | 006266S |
Shareholding
The shareholding of Therallen Pharma Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Therallen Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2.5 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Jul 2024 | 100955745 | Others | ₹2.5 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Therallen Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Therallen Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Therallen Pharma Private Limited has a workforce of 106 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
106
Active EPFO establishments
1
Employee growth
23.3%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 106 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 |
To see the full employee and EPFO history of Therallen Pharma Private Limited, buy the company report.
GST
Therallen Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCT4007R1ZW | Telangana | Active | 22 Dec 2017 |
To see the full GST registrations and return filing status of Therallen Pharma Private Limited, buy the company report.
Recent activity
Therallen Pharma Private Limited has 8 board changes on record since 2017: 2 appointments and 6 cessations. The latest: Rangaswamy Srinivasa Raghavan Gandarvakottai ceased to be Director on 21 Oct 2024.
AGM
Therallen Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Therallen Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Rangaswamy Srinivasa Raghavan Gandarvakottai ceased to be Director.
Ceased
Smitha Yalamanchili ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 2.50 Cr with Charge ID 100955745 was registered on 29 Jul 2024.
Appointed
Smitha Yalamanchili was appointed as Director.
Ceased
Krishna Yeachuri ceased to be Director.
Appointed
Srinivasa Rao Yalamanchili was appointed as Whole-Time Director.
Ceased
Hima Bindu Potluri ceased to be Director.
Ceased
Vamsi Krishna Potluri ceased to be Director.
Ceased
Ratna Rao Vissa ceased to be Additional Director.
Incorporation
24 Aug 2017
Therallen Pharma Private Limited was registered on 24 Aug 2017 with Roc Hyderabad & aged 9 years 2 months as per MCA records.
Frequently asked questions
Therallen Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 August 2017 (9+ years old) and is registered under CIN U24110TG2017PTC119091.
Therallen Pharma has 2 current directors:
- Srinivasa Rao Yalamanchili - Whole-Time Director
- Smitha Yalamanchili - Director
The latest financial statements of Therallen Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Therallen Pharma is 36AAGCT4007R1ZW, registered in Telangana.
The CIN (Corporate Identification Number) of Therallen Pharma is U24110TG2017PTC119091. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Therallen Pharma was incorporated on 24 August 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Therallen Pharma by revenue are Pharma Synth Formulations Limited, Prerana Agrochem Private Limited, Unilink Pharma Private Limited, Intracin Pharmaceuticals Private Limited, Ranq Pharmaceuticals and Excipients Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rangaswamy Srinivasa Raghavan Gandarvakottai ceased to be Director on 21 Oct 2024. Smitha Yalamanchili ceased to be Additional Director on 29 Sep 2024. Smitha Yalamanchili was appointed as Director on 21 Dec 2023. Therallen Pharma has 8 board changes on record in total.
Yes, Therallen Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0058462).
Therallen Pharma can be reached through the website therallen.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Therallen Pharma is at Plot No. 67 1st Floor Jubilee Enclave, Chitiprolu Arcade Hitech City, Hyderabad, Telangana, India – 500081.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages